Rahul R. Jasuja
Chief Executive Officer at Pelican Therapeutics, Inc.
Profile
Rahul R.
Jasuja is currently the Chief Executive Officer & Director at Pelican Therapeutics, Inc. He is also a Member at The American Association of Immunologists.
Previously, he worked as the Managing Director at Public Ventures LLC from 2004 to 2009, and as the Managing Director at Noble Capital Markets, Inc. from 2011 to 2016.
He also served as the Vice President at Idera Pharmaceuticals, Inc. from 2010 to 2011.
Additionally, he held positions as a Senior Research Analyst at Sagient Research Systems, Inc. and Soma Partners, LLC.
He was a Principal at CIM Securities LLC in 2016 and an SVP & Senior Research Analyst at FBR Capital Markets & Co. (Old) from 2016 to 2017.
He started his career as a Senior Research Analyst at Rodman & Renshaw LLC (Old) in 2002.
Dr. Jasuja is a member of the American Association for the Advancement of Science.
He completed his undergraduate studies at Saint Xavier University and obtained a graduate degree from The University of Montana in 1991.
He earned his doctorate degree from Tufts University School of Medicine in 1999.
Rahul R. Jasuja active positions
Companies | Position | Start |
---|---|---|
The American Association of Immunologists | Corporate Officer/Principal | 25/05/2010 |
Pelican Therapeutics, Inc.
Pelican Therapeutics, Inc. Hospital/Nursing ManagementHealth Services Pelican Therapeutics, Inc. operates as an immuno-oncology company. It develops biological agents that represents the next generation of tumor necrosis factor (TNF) based immunotherapy. The company was founded by Jeffrey Wolf and Josiah C. Hornblower on March 6, 2017 and is headquartered in Dallas, TX. | Chief Executive Officer | 31/03/2017 |
Former positions of Rahul R. Jasuja
Companies | Position | End |
---|---|---|
FBR Capital Markets & Co. (Old)
FBR Capital Markets & Co. (Old) Investment Banks/BrokersFinance Founded in 1989, FBR Capital Markets & Co., formerly Friedman, Billings, Ramsey & Co., is a broker/dealer headquartered in Arlington, Virginia with additional offices throughout the US. The firm is a subsidiary of FBR Capital Markets Holdings, Inc.. and their ultimate parent is FBR & Co. (NASDAQ: FBRC). In 2007, FBR Capital Markets Corp. was spun out from FBR Group as an independent investment bank, of which FBR Group retained majority ownership. FBR Capital Markets is registered with the SEC and is a member of FINRA, Nasdaq and the SIPC. FBR Capital Markets' Equity Sales & Trading Group provides institutional sales and trading services to over 1300 institutional accounts in the US, Canada, Europe, Australia and Asia. Their clients include mutual funds, hedge funds, money managers, endowments, foundations, banks, insurance companies and pension and profit sharing plans. They actively trade on behalf of clients and make markets in almost 1000 stocks traded on the NYSE, listed and OTC markets and trade more than $100 billion of securities on a per annum basis. In 2009, FBR Capital Markets began making markets in selected stocks traded on the London Stock Exchange and Euronext. In addition to agency trading in listed securities markets, they act as market-maker in Nasdaq and other OTC securities. They are one of the largest distributors of the shares of small- and mid-cap companies in public and private securities offerings and have deep trading expertise in the vertical industry groups in which the firm's investment banking and research teams specialize. These sectors include: (1) consumer (2) diversified industrials (3) energy and natural resources (4) financial institutions (5) healthcare (6) insurance (7) real estate (8) Washington policy analysis and (0) technology, media and telecommunications. The firm's analytical coverage includes a large number of small- and mid-cap companies in addition to large companies. Research is provided by FBR Capital Markets' research department, which is independent from the firm's investment banking department and has the sole authority to determine which companies receive research coverage and the recommendation contained in the coverage. | Analyst-Equity | 31/03/2017 |
CIM Securities LLC
CIM Securities LLC Investment Banks/BrokersFinance CIM Securities LLC is a registered broker-dealer headquartered in Centennial, Colorado and founded in 2002. The firm conducts the following types of business: broker or dealer retailing corporate equity securities OTC; broker or dealer selling corporate debt securities; underwriter or selling group participant of corporate securities other than mutual funds; broker or dealer selling variable life insurance; broker or dealer selling tax shelters or limited partnerships in primary distributions; non-exchange member arranging for transactions in listed securities by exchange member; and private placements of securities. | Corporate Officer/Principal | 29/11/2016 |
Noble Capital Markets, Inc.
Noble Capital Markets, Inc. Investment Banks/BrokersFinance Founded in 1984, Noble Financial Capital Markets is a broker/dealer headquartered in Boca Raton, Florida. The firm is a subsidiary of Noble Financial Group, Inc. Noble Financial Capital Markets' sales & trading team provides strategic insight and reliable solutions to nearly 500 of the dominant small-cap money managers in North America. They are members FINRA, SIPC and MSRB. Noble Financial Capital Markets offers a full array of investment services with a particular focus on under-followed, undervalued, out-of-favor small-cap emerging growth companies. Their research coverage universe includes healthcare, business services & software, defense/defense technology, energy, enterprise hardware, and media & entertainment. | Analyst-Equity | 29/06/2016 |
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | Corporate Officer/Principal | 30/01/2011 |
Public Ventures LLC
Public Ventures LLC Investment Banks/BrokersFinance Public Ventures LLC is a registered broker-dealer headquartered in Dallas, Texas. The firm was founded by Christopher Marlett and Anthony DiGiandomenico in 1997. They are a wholly-owned subsidiary of MDB Capital Holdings LLC. Public Ventures offers Go-to-Market Strategy, Market Assessments, Revenue Generation and Product Strategy for technology companies that targets the Public Sector. | Analyst-Equity | 30/12/2009 |
Training of Rahul R. Jasuja
Saint Xavier University | Undergraduate Degree |
The University of Montana | Graduate Degree |
Tufts University School of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 11 |
---|---|
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | Health Technology |
Public Ventures LLC
Public Ventures LLC Investment Banks/BrokersFinance Public Ventures LLC is a registered broker-dealer headquartered in Dallas, Texas. The firm was founded by Christopher Marlett and Anthony DiGiandomenico in 1997. They are a wholly-owned subsidiary of MDB Capital Holdings LLC. Public Ventures offers Go-to-Market Strategy, Market Assessments, Revenue Generation and Product Strategy for technology companies that targets the Public Sector. | Finance |
Sagient Research Systems, Inc.
Sagient Research Systems, Inc. Internet Software/ServicesTechnology Services Sagient Research Systems, Inc. is a publisher of specialized research and data. It develops, produces and sells proprietary research products to global enterprises, which include investment banks, mutual and hedge funds, pharmaceutical companies, academic institutions, and government agencies. Its products include placement, biomed, and catalyst trackers. The company was founded in 1999 and is headquartered in San Diego, CA. | Technology Services |
Soma Partners, LLC
Soma Partners, LLC Investment Banks/BrokersFinance SOMA Partners LLC provides investment banking and financial advisory services. The company is headquartered in South Orange, NJ. | Finance |
Noble Capital Markets, Inc.
Noble Capital Markets, Inc. Investment Banks/BrokersFinance Founded in 1984, Noble Financial Capital Markets is a broker/dealer headquartered in Boca Raton, Florida. The firm is a subsidiary of Noble Financial Group, Inc. Noble Financial Capital Markets' sales & trading team provides strategic insight and reliable solutions to nearly 500 of the dominant small-cap money managers in North America. They are members FINRA, SIPC and MSRB. Noble Financial Capital Markets offers a full array of investment services with a particular focus on under-followed, undervalued, out-of-favor small-cap emerging growth companies. Their research coverage universe includes healthcare, business services & software, defense/defense technology, energy, enterprise hardware, and media & entertainment. | Finance |
CIM Securities LLC
CIM Securities LLC Investment Banks/BrokersFinance CIM Securities LLC is a registered broker-dealer headquartered in Centennial, Colorado and founded in 2002. The firm conducts the following types of business: broker or dealer retailing corporate equity securities OTC; broker or dealer selling corporate debt securities; underwriter or selling group participant of corporate securities other than mutual funds; broker or dealer selling variable life insurance; broker or dealer selling tax shelters or limited partnerships in primary distributions; non-exchange member arranging for transactions in listed securities by exchange member; and private placements of securities. | Finance |
Pelican Therapeutics, Inc.
Pelican Therapeutics, Inc. Hospital/Nursing ManagementHealth Services Pelican Therapeutics, Inc. operates as an immuno-oncology company. It develops biological agents that represents the next generation of tumor necrosis factor (TNF) based immunotherapy. The company was founded by Jeffrey Wolf and Josiah C. Hornblower on March 6, 2017 and is headquartered in Dallas, TX. | Health Services |
FBR Capital Markets & Co. (Old)
FBR Capital Markets & Co. (Old) Investment Banks/BrokersFinance Founded in 1989, FBR Capital Markets & Co., formerly Friedman, Billings, Ramsey & Co., is a broker/dealer headquartered in Arlington, Virginia with additional offices throughout the US. The firm is a subsidiary of FBR Capital Markets Holdings, Inc.. and their ultimate parent is FBR & Co. (NASDAQ: FBRC). In 2007, FBR Capital Markets Corp. was spun out from FBR Group as an independent investment bank, of which FBR Group retained majority ownership. FBR Capital Markets is registered with the SEC and is a member of FINRA, Nasdaq and the SIPC. FBR Capital Markets' Equity Sales & Trading Group provides institutional sales and trading services to over 1300 institutional accounts in the US, Canada, Europe, Australia and Asia. Their clients include mutual funds, hedge funds, money managers, endowments, foundations, banks, insurance companies and pension and profit sharing plans. They actively trade on behalf of clients and make markets in almost 1000 stocks traded on the NYSE, listed and OTC markets and trade more than $100 billion of securities on a per annum basis. In 2009, FBR Capital Markets began making markets in selected stocks traded on the London Stock Exchange and Euronext. In addition to agency trading in listed securities markets, they act as market-maker in Nasdaq and other OTC securities. They are one of the largest distributors of the shares of small- and mid-cap companies in public and private securities offerings and have deep trading expertise in the vertical industry groups in which the firm's investment banking and research teams specialize. These sectors include: (1) consumer (2) diversified industrials (3) energy and natural resources (4) financial institutions (5) healthcare (6) insurance (7) real estate (8) Washington policy analysis and (0) technology, media and telecommunications. The firm's analytical coverage includes a large number of small- and mid-cap companies in addition to large companies. Research is provided by FBR Capital Markets' research department, which is independent from the firm's investment banking department and has the sole authority to determine which companies receive research coverage and the recommendation contained in the coverage. | Finance |
Rodman & Renshaw LLC (Old)
Rodman & Renshaw LLC (Old) Investment Banks/BrokersFinance Founded in 2003 by Cliff Rodman and Charles Renshaw, Rodman & Renshaw LLC is a full-service investment bank and broker/dealer located in New York City with an additional office in Boston. The firm is a subsidiary of Rodman & Renshaw Capital Group (NasdaqGM: RODM). The firm provides corporate finance, strategic advisory and related services to public and private companies across multiple sectors and regions. They also provide research and sales and trading services to institutional investors. Rodman & Renshaw is a leader in the PIPE and RD (registered direct offering) transaction markets. The firm's research focuses on Asia, clean technology, community & regional banks, energy, industrial and commercial services, life science/healthcare and metals and mining. Rodman & Renshaw is a member of the NASD and the SIPC. | Finance |
American Association for the Advancement of Science
American Association for the Advancement of Science Miscellaneous Commercial ServicesCommercial Services The American Association for the Advancement of Science provides science related journal, program, and education services. The firm also promotes the responsible use of science in public policy. The company was founded in 1848 and is headquartered in Washington, DC. | Commercial Services |
The American Association of Immunologists |
- Stock Market
- Insiders
- Rahul R. Jasuja